Pituitary tumor cosecreting thyrotropin and prolactin causing hyperthyroidism--a case report

Kaohsiung J Med Sci. 2000 Apr;16(4):203-9.

Abstract

We report a case of a pituitary tumor cosecreting thyrotropin and prolactin with clinical manifestation of thyrotoxicosis, which is a very rare clinical disorder. Octreotide therapy is effective in suppressing the secretion of thyrotropin, prolactin, and thyroid hormones, and by this, renders relief of symptoms and complications of thyrotoxicosis.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / drug therapy
  • Adenoma / metabolism*
  • Female
  • Humans
  • Middle Aged
  • Octreotide / therapeutic use
  • Pituitary Neoplasms / drug therapy
  • Pituitary Neoplasms / metabolism*
  • Prolactin / metabolism*
  • Thyrotoxicosis / etiology
  • Thyrotropin / metabolism*

Substances

  • Prolactin
  • Thyrotropin
  • Octreotide